|
MDN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.83495449338034E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.04034616663785E-12 |
| Normal-vs-Stage2 |
2.52959986291046E-10 |
| Normal-vs-Stage3 |
1.85418347342647E-12 |
| Normal-vs-Stage4 |
1.63247193540883E-12 |
| Stage1-vs-Stage2 |
7.617600E-01 |
| Stage1-vs-Stage3 |
9.309700E-02 |
| Stage1-vs-Stage4 |
1.856570E-03 |
| Stage2-vs-Stage3 |
3.821800E-01 |
| Stage2-vs-Stage4 |
7.084000E-02 |
| Stage3-vs-Stage4 |
1.791010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.88657986402541E-12 |
| Normal-vs-AfricanAmerican |
2.43990000425853E-08 |
| Normal-vs-Asian |
1.97859950645807E-10 |
| Caucasian-vs-AfricanAmerican |
6.068400E-01 |
| Caucasian-vs-Asian |
6.696800E-01 |
| AfricanAmerican-vs-Asian |
8.651600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64879221387082E-12 |
| Normal-vs-Female |
7.00539626308228E-12 |
| Male-vs-Female |
4.342100E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.51569867767876E-11 |
| Normal-vs-Age(41-60Yrs) |
1.52544643583497E-12 |
| Normal-vs-Age(61-80Yrs) |
1.52100554373646E-13 |
| Normal-vs-Age(81-100Yrs) |
9.91089999999861E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.672400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.063600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.895400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.716200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.194600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.749400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.346200E-02 |
| Classical-VS-Follicular |
2.143600E-02 |
| Classical-VS-Other |
5.453000E-01 |
| Classical-VS-Normal |
4.74329464594803E-11 |
| Tall-VS-Follicular |
7.313200E-01 |
| Tall-VS-Other |
8.037400E-01 |
| Tall-VS-Normal |
1.52788892648914E-12 |
| Follicular-VS-Other |
8.795400E-01 |
| Follicular-VS-Normal |
2.35000907622407E-12 |
| Other-VS-Normal |
1.383780E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.66395802586794E-12 |
| Normal-vs-N1 |
6.1739502399405E-13 |
| N0-vs-N1 |
2.515800E-01 |
|
|
